University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
83 Ergebnisse für "nanoparticle com" unter University Hospital Zurich, Research and Education Office
Layout 1
Layout 1, https://www.usz.ch/ueber-uns/Documents/wissensbericht_2011.pdf, Layout 1 11 Wissensbericht Ja hr es be ric ht Einen grossen Teil der im Wissensbericht 2011 publizierten Daten sind den Ak...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
756 Ergebnisse für "nanoparticle com" unter Somagenetix
CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines...
... CD40-targeted dendritic cell delivery of PLGA- nanoparticle vaccines induce potent anti-tumor ... CD40-targeted dendritic cell delivery of PLGA- nanoparticle vaccines induce potent anti-tumor ... CD40-targeted dendritic cell delivery of PLGA- nanoparticle vaccines induce potent anti-tumor ...
Spherical calcium phosphate nanoparticle fillers allow polymer proc...
... Spherical calcium phosphate nanoparticle fillers allow polymer processing of bone fixation devices ... , O D; Imfeld, T; Boccaccini, A R; Stark, W J (2010). Spherical calcium phosphate nanoparticle fillers ... Spherical calcium phosphate nanoparticle fillers allow polymer processing of bone fixation devices ... Spherical calcium phosphate nanoparticle fillers allow polymer processing of bone fixation devices ... Spherical calcium phosphate nanoparticle fillers allow polymer processing of bone fixation devices ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
1560 Ergebnisse für "nanoparticle com" unter ETH Entrepreneurship
Cavity-Based 3D Cooling of a Levitated Nanoparticle via Coherent Sc...
... -Based 3D Cooling of a Levitated Nanoparticle via Coherent Scattering Abstract After pioneering work on ... Cavity-Based 3D Cooling of a Levitated Nanoparticle via Coherent Scattering - Research Collection ... Cavity-Based 3D Cooling of a Levitated Nanoparticle via Coherent Scattering - Research Collection ... Cavity-Based 3D Cooling of a Levitated Nanoparticle via Coherent Scattering - Research Collection ...
Consequences of pseudo-participatory approaches towards post-disast...
... com ... com ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
751 Ergebnisse für "nanoparticle com" unter University of Zurich
UZH - UFSP Dynamik Gesunden Alterns - Dipl. rer. com. Susanne Nieke
... Susanne Nieke, Dipl. rer. com. Wissenschaftliche Mitarbeiterin ... UZH - UFSP Dynamik Gesunden Alterns - Dipl. rer. com. Susanne Nieke ... UZH - UFSP Dynamik Gesunden Alterns - Dipl. rer. com. Susanne Nieke Home Hauptnavigation Suche ... UZH - UFSP Dynamik Gesunden Alterns - Dipl. rer. com. Susanne Nieke ...
UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke
... Susanne Nieke, Dipl. rer. com. Wissenschaftliche Mitarbeiterin ... UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke ... UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke Home Main navigation Search ... UZH - URPP Dynamics of Healthy Aging - Dipl. rer. com. Susanne Nieke ...
CUTISS AG
8952 Schlieren, Grabenstrasse 11
+41 44 244 36 60
info@cutiss.swiss
After more than 15 years of research (Tissue Biology Research Unit, University Children’s Hospital Zurich), CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns.
CUTISS AG
Grabenstrasse 11
8952 Schlieren
5 Ergebnisse für "nanoparticle com" unter CUTISS AG
Fallstudie: denovoSkin™ in der rekonstruktiven pädiatrischen Verbre...
... Com ... Com ...
Virometix AG
8952 Schlieren, Wagistrasse 14
+41 (0)43 433 86 60
info@virometix.com
Virometix AG is a privately held biotechnology company developing a new generation of vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases.
Virometix AG
Wagistrasse 14
8952 Schlieren
8 Ergebnisse für "nanoparticle com" unter Virometix AG
Newsroom - Virometix AG
... August – 02 September 2022; https://www.eps2022. com/ ). With presentations on our T-cell epitope SARS-CoV ... /10.1016/j.vaccine.2021.03.081 An epitope-specific chemically defined nanoparticle vaccine for respiratory ...
... company’s structure-guided antigen design and synthetic nanoparticle delivery platform has been used to ... , combined with nanoparticle-based antigen delivery and presentation. We now await the result of our Phase 1 ... company’s structure-guided antigen design and synthetic nanoparticle delivery platform has been used to ... , combined with nanoparticle-based antigen delivery and presentation. We now await the result of our Phase 1 ...
Blutspende SRK Zürich
https://www.blutspendezuerich.ch/
8952 Schlieren, Rütistrasse 19
+41 58 272 52 52
info@zhbsd.ch
The Zurich Blood Transfusion Service SRK (ZHBSD) is a nonprofit foundation and independent partner in the healthcare sector. It ensures the supply of blood and blood products to patients in the Zurich region. Our products are made exclusively from voluntary, unpaid blood donations. We offer our services at cost-covering prices and without government subsidies. Along with ten other regional blood donation services in Switzerland, we are a member of the Swiss Red Cross Blood Donation Service (BSD SRK AG).
Blutspende SRK Zürich
Rütistrasse 19
8952 Schlieren
67 Ergebnisse für "nanoparticle com" unter Blutspende SRK Zürich
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
... Pfizer, 401 N. Middletown Rd., Pearl River, NY 10965, or at judith . absalon@ pfizer . com. *A complete ... lipid nanoparticle–formulated, nucleoside-modified RNA vaccine that encodes a prefusion stabilized ... Pfizer, 401 N. Middletown Rd., Pearl River, NY 10965, or at judith . absalon@ pfizer . com. *A complete ... lipid nanoparticle–formulated, nucleoside-modified RNA vaccine that encodes a prefusion stabilized ...
Biodistribution, migration and homing of systemically applied mesen...
... three-dimensional culture). In com- parison with MSCs, hematopoietic stem cells have a much smaller ... nanoparticle labeling in a model of heart inflammation caused by the Chagas disease parasite Trypanosoma cruzi ... three-dimensional culture). In com- parison with MSCs, hematopoietic stem cells have a much smaller ... nanoparticle labeling in a model of heart inflammation caused by the Chagas disease parasite Trypanosoma cruzi ...
Swiss Bioscience GmbH
https://www.swissbioscience.com/
8952 Schlieren, Wagistrasse 27a
+41 (0) 44 731 99 00
info@swissbioscience.com
Swiss Bioscience GmbH manufactures and banks stem cells for individuals and provides pharmaceutical grade SVF* and hADSCs** produced under cGMP*** conditions. (* Stromal Vascular Fraction extracted from human lipoaspirate, ** Human Adipose Tissue Derived Stem Cells, *** Current Good Manufacturing Practice)
Swiss Bioscience GmbH
Wagistrasse 27a
8952 Schlieren
1 Ergebnisse für "nanoparticle com" unter Swiss Bioscience GmbH
SBS | Patented Lipds Nanopartical
... patented lipid nanoparticle technology optimized for solid tumors, effective delivery of cancer drugs ... . Through the use of patented lipid nanoparticle technology optimized for solid tumors, effective delivery ...
InSphero AG
8952 Schlieren, Wagistrasse 27
+41 44 515049-0
info@insphero.com
InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.
InSphero AG
Wagistrasse 27
8952 Schlieren
10 Ergebnisse für "nanoparticle com" unter InSphero AG
Insphero
... "3D Liver Microtissues to Test Nanoparticle Toxicity", Wednesday, June 26, from 9:00 AM to 1:15 PM ... "3D Liver Microtissues to Test Nanoparticle Toxicity", Wednesday, June 26, from 9:00 AM to 1:15 PM ...
Bio-Technopark Schlieren-Zürich
8952 Schlieren, Wagistrasse 23
+41 76 336 99 44
mario.jenni@bio-technopark.ch
The Bio-Technopark offers professional support for life science start-ups in the setting up and expansion of business activities and promotes interaction between start-ups, academia and industry. A nationally and internationally respected science park has grown up at Schlieren. Through stringent selection, coaching and support, more than 30 successful start-up companies with 750 employees are located here. Eight have been acquired by large corporates, but are still active in the park. Together with 20 institutes and clinics from the University and University Hospital Zurich, an innovative mix of very young and well-established companies and academic research groups has emerged.
Bio-Technopark Schlieren-Zürich
Wagistrasse 23
8952 Schlieren
1 Ergebnisse für "nanoparticle com" unter Bio-Technopark Schlieren-Zürich
Anjarium Biosciences Raises CHF 55.5M ($61M) Series A Financing to ...
... medicine, synthetic biology and nanoparticle engineering to rationally design and produce tissue-targeted ... Company’s unique platform combines proprietary DNA-based gene vectors, natural and synthetic nanoparticle ... science and expertise at the interface of genetic medicine, synthetic biology and nanoparticle engineering ... -based gene vectors, natural and synthetic nanoparticle delivery modalities – including its novel ...